{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:09:25Z","timestamp":1790838565572,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Research Foundation of Korea (NRF) through a grant funded by the Korean government","award":["NRF-2022R1A2C2005057"],"award-info":[{"award-number":["NRF-2022R1A2C2005057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"DOI":"10.1186\/s40364-026-00953-9","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:14:15Z","timestamp":1781172855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting mRNA delivery using bio-inspired hybrid cell membrane-incorporated liposomes: a novel strategy for cancer therapy"],"prefix":"10.1186","volume":"14","author":[{"given":"Prakash","family":"Gangadaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya Lakshmi","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Dhayalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atharva A.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandasamy Nagarajan","family":"Aruljothi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Cheol","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"953_CR1","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.apsb.2023.03.001","volume":"13","author":"Y Zhong","year":"2023","unstructured":"Zhong Y, Du S, Dong Y. mRNA delivery in cancer immunotherapy. Acta Pharm Sin B. 2023;13:1348\u201357. https:\/\/doi.org\/10.1016\/j.apsb.2023.03.001.","journal-title":"Acta Pharm Sin B"},{"key":"953_CR2","doi-asserted-by":"publisher","first-page":"168385","DOI":"10.1016\/j.jmb.2023.168385","volume":"436","author":"S Meulewaeter","year":"2024","unstructured":"Meulewaeter S, Zhang Y, Wadhwa A, Fox K, Lentacker I, Harder KW, et al. Considerations on the Design of Lipid-based mRNA Vaccines Against Cancer. J Mol Biol. 2024;436:168385. https:\/\/doi.org\/10.1016\/j.jmb.2023.168385.","journal-title":"J Mol Biol"},{"key":"953_CR3","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6:1078\u201394. https:\/\/doi.org\/10.1038\/s41578-021-00358-0.","journal-title":"Nat Rev Mater"},{"key":"953_CR4","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid NanoparticlesFrom Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. ACS Nano. 2021;15:16982\u20137015. https:\/\/doi.org\/10.1021\/acsnano.1c04996.","journal-title":"ACS Nano"},{"key":"953_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","volume":"7","author":"Y Yao","year":"2020","unstructured":"Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, et al. Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front Mol Biosci. 2020;7:193. https:\/\/doi.org\/10.3389\/fmolb.2020.00193.","journal-title":"Front Mol Biosci"},{"key":"953_CR6","doi-asserted-by":"publisher","first-page":"115190","DOI":"10.1016\/j.addr.2024.115190","volume":"206","author":"M Estap\u00e9 Senti","year":"2024","unstructured":"Estap\u00e9 Senti M, Del Garc\u00eda L, Schiffelers RM. mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond. Adv Drug Deliv Rev. 2024;206:115190. https:\/\/doi.org\/10.1016\/j.addr.2024.115190.","journal-title":"Adv Drug Deliv Rev"},{"key":"953_CR7","doi-asserted-by":"publisher","first-page":"13217","DOI":"10.2147\/IJN.S489872","volume":"19","author":"I Arduino","year":"2024","unstructured":"Arduino I, Di Fonte R, Sommonte F, Lopedota AA, Porcelli L, Li J, et al. Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells. Int J Nanomed. 2024;19:13217\u201333. https:\/\/doi.org\/10.2147\/IJN.S489872.","journal-title":"Int J Nanomed"},{"key":"953_CR8","doi-asserted-by":"publisher","first-page":"100751","DOI":"10.1016\/j.mtbio.2023.100751","volume":"22","author":"W-S Liu","year":"2023","unstructured":"Liu W-S, Wu L-L, Chen C-M, Zheng H, Gao J, Lu Z-M, et al. Lipid-hybrid cell-derived biomimetic functional materials: A state-of-the-art multifunctional weapon against tumors. Mater Today Bio. 2023;22:100751. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100751.","journal-title":"Mater Today Bio"},{"key":"953_CR9","doi-asserted-by":"publisher","first-page":"939441","DOI":"10.3389\/fbioe.2022.939441","volume":"10","author":"A Liu","year":"2022","unstructured":"Liu A, Yang G, Liu Y, Liu T. Research progress in membrane fusion-based hybrid exosomes for drug delivery systems. Front Bioeng Biotechnol. 2022;10:939441. https:\/\/doi.org\/10.3389\/fbioe.2022.939441.","journal-title":"Front Bioeng Biotechnol"},{"key":"953_CR10","doi-asserted-by":"publisher","first-page":"113676","DOI":"10.1016\/j.jconrel.2025.113676","volume":"382","author":"DA Rodr\u00edguez","year":"2025","unstructured":"Rodr\u00edguez DA, Lefebvre GPR, Yang Q, Barendrecht AD, Seinen CW, Schiffelers RM, et al. Incorporation of cellular membrane protein extracts into lipid nanoparticles enhances their cellular uptake and mRNA delivery efficiency. J Control Release Off J Control Release Soc. 2025;382:113676. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113676.","journal-title":"J Control Release Off J Control Release Soc"},{"key":"953_CR11","doi-asserted-by":"publisher","first-page":"rbad045","DOI":"10.1093\/rb\/rbad045","volume":"10","author":"K Zhu","year":"2023","unstructured":"Zhu K, Xu Y, Zhong R, Li W, Wang H, Wong YS, et al. Hybrid liposome-erythrocyte drug delivery system for tumor therapy with enhanced targeting and blood circulation. Regen Biomater. 2023;10:rbad045. https:\/\/doi.org\/10.1093\/rb\/rbad045.","journal-title":"Regen Biomater"},{"key":"953_CR12","doi-asserted-by":"publisher","first-page":"1444437","DOI":"10.3389\/fimmu.2024.1444437","volume":"15","author":"Z Song","year":"2024","unstructured":"Song Z, Tao Y, Liu Y, Li J. Advances in delivery systems for CRISPR\/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles. Front Immunol. 2024;15:1444437. https:\/\/doi.org\/10.3389\/fimmu.2024.1444437.","journal-title":"Front Immunol"},{"key":"953_CR13","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1039\/d5cs00440c","volume":"55","author":"Z Li","year":"2026","unstructured":"Li Z, Li M, Lu J. Biomimetic liposomes in drug delivery: from design mechanisms to applications. Chem Soc Rev. 2026;55:1008\u201338. https:\/\/doi.org\/10.1039\/d5cs00440c.","journal-title":"Chem Soc Rev"},{"key":"953_CR14","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","volume":"10","author":"H Cao","year":"2016","unstructured":"Cao H, Dan Z, He X, Zhang Z, Yu H, Yin Q, et al. Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer. ACS Nano. 2016;10:7738\u201348. https:\/\/doi.org\/10.1021\/acsnano.6b03148.","journal-title":"ACS Nano"},{"key":"953_CR15","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1021\/nl500618u","volume":"14","author":"RH Fang","year":"2014","unstructured":"Fang RH, Hu C-MJ, Luk BT, Gao W, Copp JA, Tai Y, et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014;14:2181\u20138. https:\/\/doi.org\/10.1021\/nl500618u.","journal-title":"Nano Lett"},{"key":"953_CR16","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/biom14101212","volume":"14","author":"H Cheung","year":"2024","unstructured":"Cheung H, Kang H, Lee HJ, Chung Y, Shin H, Lee S, et al. Homologous Targeting Effect of Cancer Cell-Derived Liposomes (Memposomes) Mediated by Cell Adhesion Molecules: Role of E-cadherin. Biomolecules. 2024;14:1212. https:\/\/doi.org\/10.3390\/biom14101212.","journal-title":"Biomolecules"},{"key":"953_CR17","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1016\/j.apsb.2024.03.004","volume":"14","author":"HE Shin","year":"2024","unstructured":"Shin HE, Han J-H, Shin S, Bae G-H, Son B, Kim T-H, et al. M1-polarized macrophage-derived cellular nanovesicle-coated lipid nanoparticles for enhanced cancer treatment through hybridization of gene therapy and cancer immunotherapy. Acta Pharm Sin B. 2024;14:3169\u201383. https:\/\/doi.org\/10.1016\/j.apsb.2024.03.004.","journal-title":"Acta Pharm Sin B"},{"key":"953_CR18","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.7150\/thno.93755","volume":"14","author":"X Xu","year":"2024","unstructured":"Xu X, Xu L, Wang J, Wen C, Xia J, Zhang Y, et al. Bioinspired cellular membrane-derived vesicles for mRNA delivery. Theranostics. 2024;14:3246\u201366. https:\/\/doi.org\/10.7150\/thno.93755.","journal-title":"Theranostics"},{"key":"953_CR19","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1021\/acsnano.8b03788","volume":"13","author":"W Xie","year":"2019","unstructured":"Xie W, Deng W-W, Zan M, Rao L, Yu G-T, Zhu D-M, et al. Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy. ACS Nano. 2019;13:2849\u201357. https:\/\/doi.org\/10.1021\/acsnano.8b03788.","journal-title":"ACS Nano"},{"key":"953_CR20","doi-asserted-by":"publisher","first-page":"e2022769118","DOI":"10.1073\/pnas.2022769118","volume":"118","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang F, Liu X, Sang Y, Zhang L, Ren J, et al. Cell membrane-camouflaged liposomes for tumor cell-selective glycans engineering and imaging in vivo. Proc Natl Acad Sci U S A. 2021;118:e2022769118. https:\/\/doi.org\/10.1073\/pnas.2022769118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"953_CR21","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1002\/adma.201503323","volume":"27","author":"Q Hu","year":"2015","unstructured":"Hu Q, Sun W, Qian C, Wang C, Bomba HN, Gu Z. Anticancer Platelet-Mimicking Nanovehicles. Adv Mater Deerfield Beach Fla. 2015;27:7043\u201350. https:\/\/doi.org\/10.1002\/adma.201503323.","journal-title":"Adv Mater Deerfield Beach Fla"},{"key":"953_CR22","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1021\/acsnano.2c11691","volume":"17","author":"L Liu","year":"2023","unstructured":"Liu L, Pan Y, Zhao C, Huang P, Chen X, Rao L. Boosting Checkpoint Immunotherapy with Biomaterials. ACS Nano. 2023;17:3225\u201358. https:\/\/doi.org\/10.1021\/acsnano.2c11691.","journal-title":"ACS Nano"},{"key":"953_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nnano.2012.212","volume":"8","author":"A Parodi","year":"2013","unstructured":"Parodi A, Quattrocchi N, van de Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol. 2013;8:61\u20138. https:\/\/doi.org\/10.1038\/nnano.2012.212.","journal-title":"Nat Nanotechnol"},{"key":"953_CR24","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","volume":"15","author":"IV Zelepukin","year":"2024","unstructured":"Zelepukin IV, Shevchenko KG, Deyev SM. Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery. Nat Commun. 2024;15:4366. https:\/\/doi.org\/10.1038\/s41467-024-48838-5.","journal-title":"Nat Commun"},{"key":"953_CR25","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","volume-title":"Role of CD47 as a marker of self on red blood cells","author":"PA Oldenborg","year":"2000","unstructured":"Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. Role of CD47 as a marker of self on red blood cells. Volume 288. New York, N: Science; 2000. pp. 2051\u20134. https:\/\/doi.org\/10.1126\/science.288.5473.2051."},{"key":"953_CR26","doi-asserted-by":"publisher","first-page":"10049","DOI":"10.1021\/acsnano.6b04695","volume":"10","author":"Z Chen","year":"2016","unstructured":"Chen Z, Zhao P, Luo Z, Zheng M, Tian H, Gong P, et al. Cancer Cell Membrane-Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy. ACS Nano. 2016;10:10049\u201357. https:\/\/doi.org\/10.1021\/acsnano.6b04695.","journal-title":"ACS Nano"},{"key":"953_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature04734","volume":"441","author":"H Kato","year":"2006","unstructured":"Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441:101\u20135. https:\/\/doi.org\/10.1038\/nature04734.","journal-title":"Nature"},{"key":"953_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/science.1093616","author":"D Ss","year":"2004","unstructured":"Ss D, C TKHHSA, R e. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Sci [Internet] Sci. 2004. https:\/\/doi.org\/10.1126\/science.1093616. [cited 2026 May 13];303.","journal-title":"Sci [Internet] Sci"},{"key":"953_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Karik\u00f3","year":"2005","unstructured":"Karik\u00f3 K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005;23:165\u201375. https:\/\/doi.org\/10.1016\/j.immuni.2005.06.008.","journal-title":"Immunity"},{"key":"953_CR30","doi-asserted-by":"publisher","first-page":"e2100639","DOI":"10.1002\/adhm.202100639","volume":"11","author":"L van der Koog","year":"2022","unstructured":"van der Koog L, Gandek TB, Nagelkerke A. Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization. Adv Healthc Mater. 2022;11:e2100639. https:\/\/doi.org\/10.1002\/adhm.202100639.","journal-title":"Adv Healthc Mater"},{"key":"953_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nbt.1602","volume":"28","author":"SC Semple","year":"2010","unstructured":"Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, Cho CK, et al. Rational design of cationic lipids for siRNA delivery. Nat Biotechnol. 2010;28:172\u20136. https:\/\/doi.org\/10.1038\/nbt.1602.","journal-title":"Nat Biotechnol"},{"key":"953_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/adhm.201200138","volume":"1","author":"C-MJ Hu","year":"2012","unstructured":"Hu C-MJ, Fang RH, Zhang L. Erythrocyte-inspired delivery systems. Adv Healthc Mater. 2012;1:537\u201347. https:\/\/doi.org\/10.1002\/adhm.201200138.","journal-title":"Adv Healthc Mater"},{"key":"953_CR33","doi-asserted-by":"publisher","first-page":"e1706759","DOI":"10.1002\/adma.201706759","volume":"30","author":"RH Fang","year":"2018","unstructured":"Fang RH, Kroll AV, Gao W, Zhang L. Cell Membrane Coating Nanotechnology. Adv Mater Deerfield Beach Fla. 2018;30:e1706759. https:\/\/doi.org\/10.1002\/adma.201706759.","journal-title":"Adv Mater Deerfield Beach Fla"},{"key":"953_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.12336\/biomatertransl.2024.01.004","volume":"5","author":"H Guo","year":"2024","unstructured":"Guo H, Guo M, Xia Z, Shao Z. Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy. Biomater Transl. 2024;5:33\u201345. https:\/\/doi.org\/10.12336\/biomatertransl.2024.01.004.","journal-title":"Biomater Transl"},{"key":"953_CR35","doi-asserted-by":"publisher","first-page":"111193","DOI":"10.1016\/j.colsurfb.2020.111193","volume":"194","author":"M Farid","year":"2020","unstructured":"Farid M, Faber T, Dietrich D, Lamprecht A. Cell membrane fusing liposomes for cytoplasmic delivery in brain endothelial cells. Colloids Surf B Biointerfaces. 2020;194:111193. https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111193.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"953_CR36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1021\/acscentsci.6b00172","volume":"2","author":"J Yang","year":"2016","unstructured":"Yang J, Bahreman A, Daudey G, Bussmann J, Olsthoorn RCL, Kros A. Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes. ACS Cent Sci. 2016;2:621\u201330. https:\/\/doi.org\/10.1021\/acscentsci.6b00172.","journal-title":"ACS Cent Sci"},{"key":"953_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrd1632","volume":"4","author":"VP Torchilin","year":"2005","unstructured":"Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4:145\u201360. https:\/\/doi.org\/10.1038\/nrd1632.","journal-title":"Nat Rev Drug Discov"},{"key":"953_CR38","doi-asserted-by":"publisher","first-page":"e2301067120","DOI":"10.1073\/pnas.2301067120","volume":"120","author":"L Zheng","year":"2023","unstructured":"Zheng L, Bandara SR, Tan Z, Leal C. Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm. Proc Natl Acad Sci U S A. 2023;120:e2301067120. https:\/\/doi.org\/10.1073\/pnas.2301067120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"953_CR39","doi-asserted-by":"publisher","first-page":"e2311276120","DOI":"10.1073\/pnas.2311276120","volume":"120","author":"C Wang","year":"2023","unstructured":"Wang C, Zhao C, Wang W, Liu X, Deng H. Biomimetic noncationic lipid nanoparticles for mRNA delivery. Proc Natl Acad Sci U S A. 2023;120:e2311276120. https:\/\/doi.org\/10.1073\/pnas.2311276120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"953_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.20517\/evcna.2024.19","volume":"5","author":"L Hagedorn","year":"2024","unstructured":"Hagedorn L, J\u00fcrgens DC, Merkel OM, Winkeljann B. Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design. Extracell Vesicles Circ Nucleic Acids. 2024;5:344\u201357. https:\/\/doi.org\/10.20517\/evcna.2024.19.","journal-title":"Extracell Vesicles Circ Nucleic Acids"},{"key":"953_CR41","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/pharmaceutics17070803","volume":"17","author":"J Wang","year":"2025","unstructured":"Wang J, Chen R, Xie Y, Qin X, Zhou Y, Xu C. Endo\/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy. Pharmaceutics. 2025;17:803. https:\/\/doi.org\/10.3390\/pharmaceutics17070803.","journal-title":"Pharmaceutics"},{"key":"953_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1021\/acsbiomedchemau.2c00073","volume":"3","author":"A Golubovic","year":"2023","unstructured":"Golubovic A, Tsai S, Li B. Bioinspired Lipid Nanocarriers for RNA Delivery. ACS Bio Med Chem Au. 2023;3:114\u201336. https:\/\/doi.org\/10.1021\/acsbiomedchemau.2c00073.","journal-title":"ACS Bio Med Chem Au"},{"key":"953_CR43","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jconrel.2024.08.030","volume":"375","author":"P-S Wei","year":"2024","unstructured":"Wei P-S, Thota N, John G, Chang E, Lee S, Wang Y, et al. Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies. J Control Release Off J Control Release Soc. 2024;375:366\u201388. https:\/\/doi.org\/10.1016\/j.jconrel.2024.08.030.","journal-title":"J Control Release Off J Control Release Soc"},{"key":"953_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018;17:261\u201379. https:\/\/doi.org\/10.1038\/nrd.2017.243.","journal-title":"Nat Rev Drug Discov"},{"key":"953_CR45","doi-asserted-by":"publisher","first-page":"e1559","DOI":"10.1002\/wnan.1559","volume":"11","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Lin S, Wang X-Y, Zhu G. Nanovaccines for cancer immunotherapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11:e1559. https:\/\/doi.org\/10.1002\/wnan.1559.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"953_CR46","doi-asserted-by":"publisher","first-page":"101914","DOI":"10.1016\/j.mtbio.2025.101914","volume":"32","author":"J Guo","year":"2025","unstructured":"Guo J, Peng L, Ma P, Mai Y, Gao T, Yu N, et al. IL-15 functionalized biomimetic hybrid mRNA vaccine for enhanced NSCLC immunotherapy via synergistic activation of T cells and NK cells. Mater Today Bio. 2025;32:101914. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101914.","journal-title":"Mater Today Bio"},{"key":"953_CR47","doi-asserted-by":"publisher","first-page":"e1285","DOI":"10.1002\/ctm2.1285","volume":"13","author":"N Krishnan","year":"2023","unstructured":"Krishnan N, Fang RH, Zhang L. Cell membrane-coated nanoparticles for the treatment of cancer. Clin Transl Med. 2023;13:e1285. https:\/\/doi.org\/10.1002\/ctm2.1285.","journal-title":"Clin Transl Med"},{"key":"953_CR48","doi-asserted-by":"publisher","first-page":"114497","DOI":"10.1016\/j.jconrel.2025.114497","volume":"390","author":"M He","year":"2026","unstructured":"He M, Peng Q, Yang Q, Guan X, Liu Q, Chen R, et al. In situ reprogramming of tumor associated macrophages with versatile nano-epigenetic inhibitor for lung cancer therapy. J Control Release Off J Control Release Soc. 2026;390:114497. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114497.","journal-title":"J Control Release Off J Control Release Soc"},{"key":"953_CR49","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3390\/cancers11121836","volume":"11","author":"JC Harris","year":"2019","unstructured":"Harris JC, Scully MA, Day ES. Cancer Cell Membrane-Coated Nanoparticles for Cancer Management. Cancers. 2019;11:1836. https:\/\/doi.org\/10.3390\/cancers11121836.","journal-title":"Cancers"},{"key":"953_CR50","doi-asserted-by":"publisher","first-page":"e24606","DOI":"10.1016\/j.heliyon.2024.e24606","volume":"10","author":"A Mohammadian Farsani","year":"2024","unstructured":"Mohammadian Farsani A, Mokhtari N, Nooraei S, Bahrulolum H, Akbari A, Farsani ZM, et al. Lipid nanoparticles: The game-changer in CRISPR-Cas9 genome editing. Heliyon. 2024;10:e24606. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24606.","journal-title":"Heliyon"},{"key":"953_CR51","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3390\/pharmaceutics14102195","volume":"14","author":"MP Nikolova","year":"2022","unstructured":"Nikolova MP, Kumar EM, Chavali MS. Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment. Pharmaceutics. 2022;14:2195. https:\/\/doi.org\/10.3390\/pharmaceutics14102195.","journal-title":"Pharmaceutics"},{"key":"953_CR52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/btm2.10004","volume":"1","author":"D Dehaini","year":"2016","unstructured":"Dehaini D, Fang RH, Zhang L. Biomimetic strategies for targeted nanoparticle delivery. Bioeng Transl Med. 2016;1:30\u201346. https:\/\/doi.org\/10.1002\/btm2.10004.","journal-title":"Bioeng Transl Med"},{"key":"953_CR53","doi-asserted-by":"publisher","first-page":"e70054","DOI":"10.1002\/agt2.70054","volume":"6","author":"MB Zewail","year":"2025","unstructured":"Zewail MB, Yang G, Fan Y, Hui Y, Zhao C-X, Liu Y. Cell Membrane-Coated Lipid Nanoparticles for Drug Delivery. Aggregate. 2025;6:e70054. https:\/\/doi.org\/10.1002\/agt2.70054.","journal-title":"Aggregate"},{"key":"953_CR54","doi-asserted-by":"publisher","first-page":"29421","DOI":"10.1021\/acsnano.4c12122","volume":"18","author":"D Ge","year":"2024","unstructured":"Ge D, An R, Xue L, Qiu M, Zhu Y, Wen G, et al. Developing Cell-Membrane-Associated Liposomes for Liver Diseases. ACS Nano. 2024;18:29421\u201338. https:\/\/doi.org\/10.1021\/acsnano.4c12122.","journal-title":"ACS Nano"},{"key":"953_CR55","doi-asserted-by":"publisher","unstructured":"M\u00fclhopt S, Diabat\u00e9 S, Dilger M, Adelhelm C, Anderlohr C, Bergfeldt T, et al. Characterization of nanoparticle batch-to-batch variability. Nanomaterials Basel, Switzerland. 2018;8:311. https:\/\/doi.org\/10.3390\/nano8050311.","DOI":"10.3390\/nano8050311"},{"key":"953_CR56","doi-asserted-by":"publisher","first-page":"e2001808","DOI":"10.1002\/adma.202001808","volume":"32","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Krishnan N, Zhou J, Chekuri S, Wei X, Kroll AV, et al. Engineered Cell-Membrane-Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity. Adv Mater Deerfield Beach Fla. 2020;32:e2001808. https:\/\/doi.org\/10.1002\/adma.202001808.","journal-title":"Adv Mater Deerfield Beach Fla"},{"key":"953_CR57","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1016\/j.apsb.2024.07.009","volume":"14","author":"E Wu","year":"2024","unstructured":"Wu E, Guan J, Yu Y, Lin S, Ding T, Chu Y, et al. Exemplifying interspecies variation of liposome in vivo fate by the effects of anti-PEG antibodies. Acta Pharm Sin B. 2024;14:4994\u20135007. https:\/\/doi.org\/10.1016\/j.apsb.2024.07.009.","journal-title":"Acta Pharm Sin B"},{"key":"953_CR58","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.11.642711","author":"V Riazanski","year":"2025","unstructured":"Riazanski V, Purvina L, Cavinato L, Sui Z, Sun L, Nelson DJ. Reduction of cellular toxicity with hybrid nanoparticles for mRNA delivery. BioRxiv Prepr Serv Biol. 2025. https:\/\/doi.org\/10.1101\/2025.03.11.642711. 2025.03.11.642711.","journal-title":"BioRxiv Prepr Serv Biol"},{"key":"953_CR59","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1080\/10717544.2018.1475517","volume":"25","author":"M Okumura","year":"2018","unstructured":"Okumura M, Ichihara H, Matsumoto Y. Hybrid liposomes showing enhanced accumulation in tumors as theranostic agents in the orthotopic graft model mouse of colorectal cancer. Drug Deliv. 2018;25:1192\u20139. https:\/\/doi.org\/10.1080\/10717544.2018.1475517.","journal-title":"Drug Deliv"},{"key":"953_CR60","doi-asserted-by":"publisher","first-page":"0178","DOI":"10.34133\/bmr.0178","volume":"29","author":"A Afzal","year":"2025","unstructured":"Afzal A, Abbasi MH, Ahmad S, Sheikh N, Khawar MB. Current Trends in Messenger RNA Technology for Cancer Therapeutics. Biomater Res. 2025;29:0178. https:\/\/doi.org\/10.34133\/bmr.0178.","journal-title":"Biomater Res"},{"key":"953_CR61","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/cells14151136","volume":"14","author":"MA Rauf","year":"2025","unstructured":"Rauf MA, Rao A, Sivasoorian SS, Iyer AK. Nanotechnology-Based Delivery of CRISPR\/Cas9 for Cancer Treatment: A Comprehensive Review. Cells. 2025;14:1136. https:\/\/doi.org\/10.3390\/cells14151136.","journal-title":"Cells"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-00953-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:38:18Z","timestamp":1783604298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-00953-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["953"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-00953-9","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"An AI-based tools (Wordvice AI or ChatGPT by OpenAI, GPT-5.2, accessed May 2026) was used under author supervision in a limited manner to improve English expression, clarify structure, and adjust word count in manuscript text and answer reviewers. The authors reviewed and edited the content independently and take full responsibility for the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}